Von Roemeling C, Doonan BP, Klippel K, Schultz D, et al. Oral IRAK-4 inhibitor CA-4948 is blood-brain barrier penetrant and has single-agent activity against CNS lymphoma and melanoma brain metastases. Clin Cancer Res 2023 Feb 7:CCR-22-1682. doi: 10.1158/1078-0432.CCR-22-1682.
PMID: 36749885